European Union health ministers will discuss the coronavirus pandemic and the spread of the Omicron variant on Tuesday, but are not expected to make any decision on easing travel restrictions, three sources told Reuters.
Johnson & Johnson has cut by half expected deliveries of COVID-19 vaccines to the European Union this week, an EU official told Reuters on Monday, compounding supply problems the company has faced.
By Reuters Staff
1 Min Read
BRUSSELS, Jan 22 (Reuters) - AstraZeneca told European Union officials on Friday it would cut deliveries of its COVID-19 vaccine to the bloc by 60% to 31 million doses in the first quarter of the year due to production problems, a senior official told Reuters.
The company was expected to deliver to the 27 EU countries about 80 million doses by the end of March, the official who was involved in the talks said.
The company had also agreed to deliver more than 80 million doses in the second quarter, but on Friday was not able to indicate delivery targets for the April-June period due to the production issues, the official said.